Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Annals of Global Health|August 26, 2021
Setting Up a Medical Oncology Educational Program in Sub-Saharan AfricaSara Bravaccini, Patrizia Serra, Dino Amadori, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2014
Automated preparation of chemotherapy: quality improvement and economic sustainabilityCarla Masini, Oriana Nanni, Sara Antaridi, et al.Cancers|September 27, 2025
Breast Immunology Network: Toward a Multidisciplinary and Integrated Model for Breast Cancer Care in ItalyAndrea Botticelli, Ovidio Brignoli, Francesco Caruso, et al.Expert Review of Pharmacoeconomics & Outcomes Research|May 15, 2020
The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematologyMattia Altini, Nicola Gentili, William Balzi, et al.The Prostate|September 30, 2014
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamideVincenza Conteduca, Salvatore Luca Burgio, Cecilia Menna, et al.Current Oncology (Toronto, Ont.)|May 24, 2024
Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology TrialsLorenzo Gasperoni, Carla Masini, Giada Toscano, et al.Cancer Medicine|November 14, 2019
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan AfricaPatrizia Serra, Deogratias M Katabalo, Nestory Masalu, et al.Pharmaceuticals (Basel, Switzerland)|July 2, 2021
[18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality IssueValentina Di Iorio, Stefano Boschi, Anna Sarnelli, et al.Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Production and Quality Control of [68Ga]Ga-FAPI-46: Development of an Investigational Medicinal Product Dossier for a Bicentric Clinical TrialAlessandro Cafaro, Cristina Cuni, Stefano Boschi, et al.Minerva Medica|September 21, 2020
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemiaAlessandro Cafaro, Maria B Giannini, Paolo Silimbani, et al.Pageof 4